A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB)

New data suggest that metformin administered to pregnant mothers may have unintended effects on the fetus, prompting the need for further assessment of the drug’s risk-benefit ratio.

Metabolic changes in the neurons of patients with amyotrophic lateral sclerosis may be reversed with vitamin B3 supplements.

A breakthrough stem cell transplant technology uses donated cadaver eyes to restore vision in patients with retinal degeneration.

From the public sector to innovative startups and industry giants, A*STAR scholars are blazing the trail across Singapore’s research ecosystem.

Researchers engineer specialized T cells that can transiently and effectively attack liver cancer cells even in the presence of immunosuppressive drugs.

From music streaming technology to COVID-19 tests, A*STAR Assistant Chief Executive (Enterprise) Sze Wee Tan details how the agency is bringing their innovations out of the lab and into the real world.

Through the years, A*STAR has always stood at the forefront of science and technology and innovation. Here’s how A*STAR came to be and what it has in store in the upcoming decades.

Broad-acting antibiotics can disrupt the gut microbiome and create the perfect conditions for potentially life-threatening yeast infections to flourish.

A protein in cilia called CFAP53 is responsible for the distinct beat patterns during embryonic development, researchers say.

Induced pluripotent stem cells have helped researchers map the role of the RFX6 gene in a rare congenital disorder known as Mitchell-Riley Syndrome.

Asian patients with suspected but undiagnosed rare genetic diseases could get answers sooner thanks to next-generation sequencing technologies.

Scientists identify a key molecular marker of muscle stem cells, providing novel insights into the mechanisms around muscle regeneration.